Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.
Summary
- On May 31, 2024, Eric Sievers, the Chief Medical Officer of BioAtla, Inc., reported a change in beneficial ownership of the company's common stock.
- The transaction involved the withholding of 572 shares by BioAtla to satisfy income tax obligations related to the vesting and net settlement of previously reported restricted stock units.
- The price per share for the withholding was $1.51.
- Following the transaction, Sievers directly owns 209,278 shares of BioAtla common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes. It doesn't inherently indicate positive or negative sentiment regarding the company's performance.
Industry Context
Form 4 filings are standard practice for company insiders to report changes in their ownership of company stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine adjustment of share ownership for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: Shares withheld by the issuer to cover tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.